Results 111 to 120 of about 1,328,750 (347)

A call to implement preclinical study registration in animal ethics review. [PDF]

open access: yesPLoS Biol, 2023
Jeffers MS   +6 more
europepmc   +1 more source

The Animal Ethics of Temple Grandin: A Protectionist Analysis [PDF]

open access: yes, 2019
This article brings animal protection theory to bear on Temple Grandin’s work, in her capacity both as a designer of slaughter facilities and as an advocate for omnivorism.
Lamey, Andy
core  

Next‐generation proteomics improves lung cancer risk prediction

open access: yesMolecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj   +4 more
wiley   +1 more source

HAEMATOBIOCHEMICAL CHANGES ASSOCIATED WITH CUTANEOUS VASCULITIS IN DOGS [PDF]

open access: yesJournal of Veterinary and Animal Sciences, 2019
The present study documents the haematological and serum biochemical parameters in cutaneous vasculitis in dogs. Cutaneous vasculitis is the inflammation of blood vessels of dermis and subcutaneous tissue.
G.R. Chaitra   +4 more
doaj  

Research, values, and ethics in organic agriculture - examples from sustainability, precaution, nature quality, and animal welfare [PDF]

open access: yes, 2000
Agricultural systems are characterised by involving both natural and social systems. Organic farming, in particular, has developed as part of a wider organic movement incorporating producers, manufacturers and consumers.
Alrøe, Hugo Fjelsted   +1 more
core  

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

open access: yesMolecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad   +35 more
wiley   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Home - About - Disclaimer - Privacy